Plasticity in neuronal circuits enables animals to adapt to an everchanging environment. However, the loci and nature of experiencedependent changes in circuit function that drive adaptive and pathological behaviours remain largely unknown. Modern techniques such as optogenetics 1 and chemogenetics 2 permit the sequential screening of targeted elements in circuits with complex input and output patterns, but unbiased approaches are necessary to identify new components that play critical roles in the behavioural changes of interest. One such approach uses the expression of immediate early genes to identify the neuronal ensembles activated by a defined experience 3, 4 but, as currently used, this approach does not reveal the connectivity of these ensembles. Brain imaging techniques such as functional MRI or positron-emission tomography also provide insights into unexpected experience-dependent macroscopic activity changes, but lack cellular resolution. Thus, there is a need for additional methods that facilitate unbiased identification of the circuit substrates of experience-dependent behavioural changes. Here, we present evidence that rabies virus-based monosynaptic tracing facilitates screening of circuit elements that contribute to behavioural changes by allowing whole-brain mapping of monosynaptic inputs 5, 6 to defined starter neuronal populations and their input-output relationships [7] [8] [9] . To test the utility of a rabies virus-based approach for screening of behaviourally relevant experience-dependent circuit adaptations, we initially focused on the ventral tegmental area (VTA), a circuit node that is critical for a variety of experience-dependent behaviours [10] [11] [12] . The diverse array of inputs to and input-output relationships of dopamine and GABA (γ -aminobutyric acid) cells in the VTA have been extensively elucidated using rabies virus methods 5, 7 . We used drugs of abuse as a robust trigger of experience-dependent plasticity, focusing on cocaine, which elicits long-lasting behavioural adaptations including locomotor sensitization (LMS) and conditioned place preference (CPP). Our unbiased input screen revealed an unexpected critical role for the GPe, which has been implicated in motor control 13 , habit formation 14 and Parkinson's disease 15 but not studied in relation to addictionrelated behaviours triggered by drugs of abuse. Our findings provide proof of principle for the utility of this approach while implicating the GPe in the establishment of drug-evoked behavioural plasticity.
Plasticity in neuronal circuits enables animals to adapt to an everchanging environment. However, the loci and nature of experiencedependent changes in circuit function that drive adaptive and pathological behaviours remain largely unknown. Modern techniques such as optogenetics 1 and chemogenetics 2 permit the sequential screening of targeted elements in circuits with complex input and output patterns, but unbiased approaches are necessary to identify new components that play critical roles in the behavioural changes of interest. One such approach uses the expression of immediate early genes to identify the neuronal ensembles activated by a defined experience 3, 4 but, as currently used, this approach does not reveal the connectivity of these ensembles. Brain imaging techniques such as functional MRI or positron-emission tomography also provide insights into unexpected experience-dependent macroscopic activity changes, but lack cellular resolution. Thus, there is a need for additional methods that facilitate unbiased identification of the circuit substrates of experience-dependent behavioural changes. Here, we present evidence that rabies virus-based monosynaptic tracing facilitates screening of circuit elements that contribute to behavioural changes by allowing whole-brain mapping of monosynaptic inputs 5, 6 to defined starter neuronal populations and their input-output relationships [7] [8] [9] . To test the utility of a rabies virus-based approach for screening of behaviourally relevant experience-dependent circuit adaptations, we initially focused on the ventral tegmental area (VTA), a circuit node that is critical for a variety of experience-dependent behaviours [10] [11] [12] .
The diverse array of inputs to and input-output relationships of dopamine and GABA (γ -aminobutyric acid) cells in the VTA have been extensively elucidated using rabies virus methods 5, 7 . We used drugs of abuse as a robust trigger of experience-dependent plasticity, focusing on cocaine, which elicits long-lasting behavioural adaptations including locomotor sensitization (LMS) and conditioned place preference (CPP). Our unbiased input screen revealed an unexpected critical role for the GPe, which has been implicated in motor control 13 , habit formation 14 and Parkinson's disease 15 but not studied in relation to addictionrelated behaviours triggered by drugs of abuse. Our findings provide proof of principle for the utility of this approach while implicating the GPe in the establishment of drug-evoked behavioural plasticity.
Screen for cocaine-induced input changes
Cocaine administration induces modification of synapses on dopamine and GABA neurons in the VTA (VTA-DA and VTA-GABA neurons, respectively) 16 but the identities of cells providing those inputs are largely unknown. To test whether rabies virus monosynaptic tracing might reveal the identities of inputs altered by cocaine, we first used the rabies monosynaptic input tracing technique 17 , where animals were given a single injection of cocaine (15 mg kg −1 ) or saline one day before injection of the rabies virus, RVdG (Fig. 1a) . Unbiased analysis of the labelled input cells from 22 brain regions comprising more than 90% of long-range inputs to VTA-DA neurons revealed that although the global maps were quantitatively similar, labelling proportionally increased or decreased in cocaine-treated animals in a small subset of regions, with inputs from the GPe displaying the largest proportional change (Fig. 1b) .
To determine whether similar labelling changes occurred in response to different classes of abused substances, as occurs with synaptic adaptations onto VTA-DA neurons 16 , we administered single doses of amphetamine, morphine, nicotine, or the psychoactive but nonaddictive substance fluoxetine. The drugs of abuse increased labelling of GPe cells whereas fluoxetine did not (Fig. 1c, Extended Data Fig. 1a ). As previous work using rabies virus revealed that VTA-DA and VTA-GABA neurons receive similar inputs 7 , we next used the GAD2-Cre mouse driver line to test whether cocaine induced similar changes in labelling of cells making monosynaptic contacts onto midbrain GABA neurons in the VTA and the nearby substantia nigra pars reticulata (SNr) (Fig. 1d) . Cocaine again elicited a proportional increase in labelling of GPe cells compared to saline injections (Fig. 1e ).
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Cocaine enhances GPe-PV neuron activity
The four brain regions with the largest drug-induced change in labelling were the GPe, anterior cortex (Ant. Ctx.), medial habenula (MHb), and nucleus accumbens medial shell (NAcMedS) (Fig. 1c, Extended Data  Fig. 1a ). While the latter three have been previously implicated in the behavioural adaptations caused by drugs of abuse 11 , the potential role of the GPe has not been investigated, to our knowledge. To investigate what the increase in rabies virus labelling of GPe inputs onto VTA-DA and VTA-GABA cells tells us about the effects of cocaine, we used parvalbumin (Pvalb)-Cre or Pvalb-Flp mouse driver lines to specifically target parvalbumin neurons in the GPe (GPe-PV cells) (as the majority of rabies-labelled GPe cells making synapses onto VTA-DA neurons co-stained with parvalbumin (305 of 367; Extended Data Fig. 1b) ). Visualization of axons of GPe-PV neurons expressing a membranetagged GFP demonstrated that these cells send major projections to a range of brain regions, including the forebrain and thalamus (Extended Data Fig. 2a, b) . Consistent with previous work 18 , the main GPe projection to the midbrain was to the SNr, which contains mostly GABA neurons 19 , while dopamine neuron-containing nuclei such as the substantia nigra pars compacta (SNc) or VTA received fewer inputs (Extended Data Fig. 2c, d) .
To determine whether the cocaine-induced increase in rabies virus labelling of GPe cells reflected an increase in the number of synaptic contacts, we injected the adeno-associated virus (AAV) AAV-FLEx loxP -mGFP-2A-synaptophysin-mRuby, which labels putative presynaptic sites (Fig. 2a) , into the GPe of Pvalb-Cre mice and imaged them after a cocaine or saline injection about 1 month later (Fig. 2b) . The density and volume of labelled puncta in the SNr were indistinguishable in saline versus cocaine-treated animals (Fig. 2c, d ), suggesting that there was no change in synapse number. Next, we assessed potential changes in synapse strength, as single doses of drugs of abuse can enhance the synaptic strength of both excitatory and inhibitory inputs into the ventral midbrain 16 . We injected a Flp-dependent AAV expressing channelrhodopsin (AAV-FLEx FRT -ChR2) into the GPe of Pvalb-Flp mice and conducted whole-cell recordings from SNr neurons in acute slices about 1 month later. Calcium in the extracellular recording solution was replaced by strontium to enable measurement of quantal events 20 ( Fig. 2e, f) . No change in the amplitude or frequency of quantal events was observed in slices prepared from cocaine-versus salinetreated mice (Fig. 2g, h ), suggesting that cocaine did not elicit a change in the strength of the inhibitory synapses made by GPe-PV neurons onto SNr neurons.
Finally, we assessed whether the spontaneous activity of GPe-PV neurons in vivo was altered by cocaine by expressing the fluorescent Ca 2+ indicator GCaMP6f in GPe-PV neurons and collecting population Ca
2+
-dependent signals using fibre photometry (Fig. 2i) . Although Figure 1 | Cocaine-induced changes to VTA neuron inputs. a, Strategy for labelling inputs to VTA-DA neurons. 1, 2, and 3 represent sequential steps in the experiment: AAV infection, rabies infection, and rabies spread. b, Fraction of total GFP + inputs from each site relative to total quantified inputs. Highlighted regions represent P < 0.05 (P = 0.04, 0.04, 0.02, 0.02 for EAM, EP, GPe, and ZI, respectively). c, Combined data for administration of drug of abuse (n = 4, 5, 5, 4 for cocaine, amphetamine, morphine, and nicotine, respectively) or control (saline, n = 4; fluoxetine, n = 3: P = 0.005, 0.007, 0.05, 0.05 for GPe, MHb, NAcMedS and anterior cortex, respectively). d, e, Strategy (d) and quantification (e) of labelling inputs to ventral midbrain GABA neurons (GPe, P = 0.01). For all figures, unless otherwise noted, statistical analyses used paired t-tests and error bars represent s.e.m. The schematics of the mouse brain in this figure were adapted from ref. 33 . Ant. Ctx., anterior cortex; BNST, bed nucleus of the stria terminalis; CeA, central amygdala; DCN, deep cerebellar nuclei; DR, dorsal raphe; DStr, dorsal striatum; EAM, extended amygdala; EP, entopeduncular nucleus; LDT, laterodorsal tegmentum; LH, lateral hypothalamus; LHb, lateral habenula; MHb, medial habenula; NAcMedS/ NAcLatS/NAcCore, nucleus accumbens medial shell/lateral shell/core; PBN, parabrachial nucleus; PO, preoptic nucleus; PVH, paraventricular hypothalamus; VP, ventral pallidum; ZI, zona incerta. cocaine administration had no significant acute effect, population activity had increased twofold by the following day (Fig. 2j, k) . To assess whether this increase might reflect changes in intrinsic excitability, we injected AAV-FLEx loxP -GFP into the GPe of Pvalb-Cre mice and made targeted whole-cell current clamp recordings from acute GPe slices prepared one day after the mice received saline or cocaine injections (Fig. 2l) . GPe-PV neurons from cocaine-treated mice were more excitable, in that more action potentials were generated by depolarizing current injection steps (Fig. 2m, n) with no change in the input resistances of the cells (Fig. 2n ). These results demonstrate that a single exposure to cocaine triggers increases in the spontaneous activity and excitability of GPe-PV neurons.
Input activity modulates rabies labelling
To investigate whether the cocaine-induced changes in rabies virus labelling of GPe-PV input neurons result from the observed changes in their activity, we expressed transgenes in GPe-PV neurons that permit manipulation of their activity levels while simultaneously performing rabies virus transsynaptic labelling. Chronic activity manipulations bidirectionally influenced the extent of GPe neuronal labelling: chronic inhibition of GPe-PV neuron activity with the inhibitory DREADD hM4Di 2 or K ir 2.1 21 decreased rabies virus labelling of GPe neurons compared to control and yellow fluorescent protein (YFP)-expressing mice, whereas excitation using hM3Dq 2 , on average, increased labelling (Fig. 3d) . As a control for these manipulations, we examined labelling in the NAcMedS and found no effect due to expressing any of these transgenes in GPe-PV neurons (Fig. 3e) .
To determine whether the effects of chronic activity changes on rabies virus transsynaptic labelling generalized to other brain regions, we performed the same genetic manipulations on D1 receptorexpressing medium spiny neurons (MSNs) in the NAcMedS, the labelling of which was decreased by drugs of abuse (Fig. 1c, Extended  Data Fig. 1a, c) . Parallel to the effects of manipulating GPe-PV neurons, chronic NAcMedS inhibition using hM4Di or K ir 2.1 reduced labelled inputs into the NAcMedS, whereas activation with hM3Dq enhanced NAcMedS labelling (Fig. 3h) . Unexpectedly, although NAcMedS inhibition did not alter labelling of GPe neurons, NAcMedS activation increased labelled GPe inputs (Fig. 3g) , suggesting that activation of D1 MSNs in the NAcMedS indirectly increases GPe activity. Together, these experiments provide evidence that rabies-mediated transsynaptic labelling from starter neurons is influenced by the level of activity in input cell populations. Furthermore, they support the hypothesis that cocaine and other drugs of abuse chronically increase the level of GPe-PV neuron activity and that this accounts for the observed increase in GPe neuron labelling by the rabies virus.
Behavioural changes require GPe activity
To determine whether the cocaine-elicited changes in GPe-PV neuron activity revealed by rabies virus tracing are functionally relevant and necessary for cocaine-induced behavioural adaptations, we tested whether inhibition of GPe-PV neurons influenced two forms of cocaine-induced behavioural plasticity, LMS and CPP. Inhibition of activity in GPe-PV neurons using expression of any one of three transgenes-encoding hM4Di, K ir 2.1 or the tetanus toxin light chain (TeTxLc), which inhibits presynaptic vesicle release 22 -prevented cocaine-induced LMS (Fig. 4a-c) , while having no effect on basal locomotion and only a modest effect on cocaine-induced locomotion upon initial administration (Extended Data Fig. 3 ). Furthermore, 
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there was a positive correlation between the number of rabies-labelled GPe inputs and the magnitude of LMS in a two-day injection protocol for cocaine as well as other addictive drugs (Extended Data Fig. 4 ). Similar results were obtained for cocaine-elicited CPP: using a four-day protocol (Fig. 4d) , inhibition of GPe-PV activity through expression of hM4Di, K ir 2.1 or TeTxLc prevented CPP (Fig. 4e, f) . Inhibition of GPe-PV neurons with hM4Di also prevented morphine-induced LMS and CPP (Extended Data Fig. 5 ), implying that the role of these neurons may generalize to other abused substances.
A limitation of these experiments is that GPe-PV neurons project to several brain regions (Extended Data Fig. 2 ) and thus the transgene-mediated inhibition of these neurons was not target-specific. To limit the expression of an inhibitory transgene specifically to those GPe-PV neurons that project to the midbrain, we injected the retrogradely transported CAV-FLEx loxP -Flp into the midbrain of Pvalb-Cre mice and the Flp-dependent AAV-FLEx FRT -K ir 2.1 into the GPe, enabling K ir 2.1 expression to be restricted to Cre-expressing GPe-PV neurons projecting to the midbrain (Extended Data Fig. 6a ). This manipulation prevented both cocaine-elicited LMS and CPP (Extended Data Fig. 6b, c) . However, subsequent axon tracing experiments revealed that the GPe-PV neurons projecting to the midbrain collateralize extensively (Extended Data Fig. 7 ), limiting the interpretation of this experiment. To inhibit the GPe-PV neuron projections within the midbrain specifically, we expressed hM4Di in GPe-PV neurons and infused slow-release clozapine N-oxide (CNO) microspheres 23 into the midbrain (Fig. 4g ). This local inhibition was sufficient to block cocaine-induced LMS (Fig. 4h) and CPP (Fig. 4i ). After waiting a week to allow depletion of CNO, the same mice were re-tested using the same protocols, and expressed significant LMS and CPP (Fig. 4h, i ). These results demonstrate that activity in the projection of GPe-PV neurons to the midbrain is necessary for two forms of cocaine-induced behavioural plasticity.
GPe-PV neurons disinhibit VTA-DA neurons
Does the cocaine-induced increase in activity in inhibitory GPe-PV neurons influence dopamine neuron activity, which is required for induction of LMS and CPP (Extended Data Fig. 8 )? Given that the major projection from GPe-PV neurons to the midbrain is into the SNr (Extended Data Fig. 2 ), a simple hypothesis is that GPe-PV neurons strongly inhibit SNr neurons that tonically inhibit dopamine neurons. Thus, activation of GPe-PV neurons would increase dopamine neuron YFP (7) hM4Di (9) K ir 2.1 (13) hM3Dq (10) Control (20) YFP (7) hM4Di (10) K ir 2.1 (9) hM3Dq (7) Control (20) YFP (7) hM4Di (9) K ir 2.1 (13) hM3Dq (10) Control (20) YFP (7) hM4Di (10) K ir 2.1 (9) hM3Dq ( . Combined controls (uninjected and YFP) were assigned a value of 1. GPe inhibition reduced (hM4Di, P = 0.004; K ir 2.1, P < 0.0001) and activation increased (hM3Dq, P = 0.016) labelled inputs. e, Quantification of labelled inputs in NAcMedS (hM4Di, P = 0.98; K ir 2.1, P = 0.90; hM3Dq, P = 0.88). f-h, NAcMedS manipulation. f, Experimental strategy. g, NAcMedS-D1 inhibition had no effect on labelling of GPe inputs (hM4Di, P = 0.13; K ir 2.1, P = 0.65) while activation increased labelling (hM3Dq, P < 0.001). h, NAcMedS-D1 inhibition decreased (hM4Di, P = 0.02; K ir 2.1, P = 0.03) while activation increased (hM3Dq, P = 0.007) labelling of NAcMedS inputs. The schematics of the mouse brain in this figure were adapted from ref. 33 . 
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TeTxLc ( f, GPe-PV neuron inhibition prevented CPP (hM4Di, P = 0.019; K ir 2.1, P = 0.030; TeTxLc, P = 0.029). g-i, Inhibition of GPe-PV projections to midbrain. g, Slow-release CNO microspheres were injected into ventral midbrain in animals expressing hM4Di or YFP in GPe-PV neurons. h, i, Both LMS (h; P = 0.0005) and CPP (i; P = 0.0094) were blocked in hM4Di-expressing animals. When tested again after CNO washout, the same mice developed LMS (h; P = 0.047) and CPP (i; P = 0.0078). The schematics of the mouse brain in this figure were adapted from ref. 33. activity via disinhibition, despite some direct synaptic inhibition of dopamine neurons. We tested this hypothesis in several ways. First, to examine the functional strength of GPe-PV neuron connections to midbrain dopamine and GABA neurons, we injected AAV-FLEx FRT -ChR2 into the GPe of either DAT-Cre;Pvalb-Flp (DAT is also known as Slc6a3) or GAD2-Cre;Pvalb-Flp double transgenic mice, AAV-FLEx loxP -GFP into the VTA to label dopamine or GABA neurons (Fig. 5a) , and retrobeads into either the NAcMedS or nucleus accumbens lateral shell (NAcLatS) to demarcate one of two VTA-DA subpopulations whose inputs are modified by cocaine 24 . We then measured monosynaptic inhibitory postsynaptic currents (IPSCs) by whole-cell recordings in acute slices. Optical stimulation of GPe-PV neuron axons evoked large IPSCs in the majority (63%, n = 24) of SNr-GABA neurons (Fig. 5b, c) . In the same sets of slices using the same optical stimulation, the connectivity onto VTA neurons was much smaller (5-14%), as was the size of the IPSCs in cells in which they could be detected (Fig. 5b, c,  Extended Data Fig. 9 ). These results demonstrate that functionally, GPe-PV neurons exhibit much stronger inhibitory connections onto SNr-GABA neurons than onto VTA-DA or VTA-GABA neurons, and thus the GPe-PV synapses in the VTA appear to be of limited functional importance.
Second, we tested whether manipulating activity in SNr-GABA neurons could alter the development of LMS and CPP. Activation of SNr-GABA neurons with hM3Dq prevented the development of LMS and CPP (Extended Data Fig. 10a-c) , whereas concurrently inhibiting SNr-GABA neurons with hM4Di during chronic GPe-PV neuron inhibition rescued cocaine-mediated behavioural plasticity (Extended Data Fig. 10d-f) . These results suggest that GPe-PV neuron inhibition prevents LMS and CPP by enhancing the activity of SNr-GABA neurons.
Third, we examined whether SNr-GABA neurons provide direct inhibition to dopamine neurons using a modified rabies virus input tracing strategy 25 to label local inputs onto dopamine neurons and combining this with in situ hybridization for Gad1 and Gad2 mRNA (Fig. 5d, e) . Quantitatively, SNr-GABA neurons were the second-largest source of inhibitory inputs to dopamine neurons (Fig. 5f ).
Fourth, we tested whether changes in GPe-PV neuron activity influenced integrated VTA-DA neuron activity using Fos labelling. In YFPexpressing mice, acute cocaine administration caused a clear increase in Fos + dopamine neurons compared to saline-injected mice 90 min after injection (Fig. 5j) . Inhibition of GPe-PV neurons with hM4Di had no effect in saline-treated animals but completely prevented the increase in cocaine-treated mice, as did expression of K ir 2.1 (Fig. 5j) . Conversely, activation of GPe-PV neurons by ChR2 increased Fos expression in dopamine neurons to a degree similar to that elicited by cocaine (Fig. 5j) .
Finally, to test the effect of activating GPe-PV neurons on VTA-DA neuron activity directly in vivo, we injected a Flp-dependent redshifted opsin (bReachES) 26 into the GPe and a Cre-dependent GCaMP6f into the VTA of DAT-Cre;Pvalb-Flp double transgenic mice, and recorded population activity from midbrain dopamine neurons with fibre photometry while optically activating GPe-PV neurons (Fig. 5k) . Stimulation of GPe-PV neurons caused a small but significant increase in GCaMP6f fluorescence in VTA-DA neurons (Fig. 5l, m) . Together, these results indicate that GPe-PV neurons control VTA-DA neuron activity through disynaptic disinhibition via SNr-GABA neurons (Fig. 5n) . 
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Concluding remarks
The association of specific experience-dependent circuit changes with corresponding behavioural adaptations has been hampered by a lack of suitable methodology. While most investigations of circuit function rely on a candidate approach that takes advantage of cell-type specific manipulations, such studies are limited by the requirement for a priori assumptions regarding the roles of targeted populations. Given the complexity of circuit mechanisms that mediate animal behaviours, unbiased approaches offer advantages for identifying the array of specific neuroplastic changes that drive behavioural changes. Here, we demonstrate that neural activity influences the extent of labelling by the rabies monosynaptic input tracing method. This property enabled us to identify circuit elements that were modified by experience in a behaviourally relevant manner. Specifically, the activity-dependence of rabies labelling enabled us to identify an underappreciated circuit node, the GPe, as a key player in cocaine-induced behavioural adaptations. As a core component of the dorsal striatal indirect pathway implicated in motor control 13 and associated disorders 15, 27 , the GPe had not previously (to our knowledge) been directly linked to addictive behaviours. Using a number of different assays, we demonstrated that the effect of enhanced GPe input to the midbrain is to increase VTA-DA neuron activity via a mechanism of disinhibition (Fig. 5n) . Our findings provide a novel circuit mechanism for influencing VTA-DA neuron activity, and confirm that this mechanism has a critical role in druginduced behavioural adaptations 11, 28 (Extended Data Fig. 8 ). Given that the rabies virus transsynaptic technique has been used successfully to map inputs onto cell populations in many brain areas 5-9,29-32 , we anticipate that this method will be generalizable and complementary to other circuit analysis methods 1,2 for elucidating how activity changes in connected ensembles orchestrate features of complex behaviours.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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MethOdS
No statistical methods were used to predetermine sample size. Experiments described in Figs 1, 2a- -G was injected into the VTA of 4-6-week-old mice. Thirteen days later, a single dose of cocaine (15 mg/kg), amphetamine (10 mg/kg), nicotine (0.5 mg/kg), morphine (10 mg/kg), fluoxetine (10 mg/kg) or saline was injected intraperitoneally (IP), and the mouse was placed in a new cage for thirty minutes before being returned to its home cage. On the following day, RVdG was injected into the VTA. After recovery, mice were housed in a BSL2 facility for 5 days to allow rabies spread and GFP expression. P values presented in Fig. 1 were not corrected for multiple comparisons.
For identification of local GABAergic inputs to VTA-DA neurons, 100 nl of a 1:1 volume mixture of AAV-CAG-FLEx loxP -TC66T and AAV-CAG-FLEx loxP -G was injected into the VTA of 4-6-week-old mice. Two weeks later, RVdG was injected into the VTA, and virus allowed to spread for five days. For in situ hybridization, midbrain sections were stained with probes for Gad1 and Gad2
6
, and imaged on a Zeiss LSM780 microscope at 20× magnification. Imaging, histology and wholebrain quantification were performed as previously described 7 . In Fig. 5f , the VTA included the parabrachial pigmented area (PBP) and paranigral nucleus (PN). Data were averaged from three mice.
Coordinates Owing to the large sample sizes of the experiments involving targeted input activity manipulations, only inputs from the GPe and NAc were quantified. Inputs from the NAcCore and NAcLatS were used for normalization because the percentage of total rabies-labelled inputs from these regions was relatively invariant, regardless of whether injections were located more medially or laterally in the VTA 7 , or whether a drug of abuse had been injected (Fig. 1, Extended Data  Fig. 1a) . Rabies input tracing with two-day LMS procedure. To examine the relationship between rabies-labelled inputs in the GPe and locomotor sensitization to cocaine injections using a two-dose procedure, in DAT-Cre mice, 100 nl of a 1:1 volume mixture of AAV-FLEx loxP -TC and AAV-FLEx loxP -G was injected into the VTA. On days 1 and 2, mice received IP injections of saline and were habituated to an open field chamber equipped with infrared lasers for motion tracking. On day 3, mice were injected with one of the following: cocaine (15 mg/kg), amphetamine (1 mg/kg), nicotine (0.5 mg/kg) or morphine (10 mg/kg), and placed in the same open field chamber. On day 4, RVdG was injected into the VTA. On day 9, mice were injected with the same dose of the same drug they had received on day 3, and their locomotion was tracked in the open field. Experiments were terminated immediately thereafter. The rabies-labelled inputs into the GPe were quantified and normalized to the sum of inputs from the NAcLatS and NAcCore. Axon projection quantification. Images were obtained and quantified as previously described 7 , except that three sections were used for each region and were averaged to obtain the final value. Four brains were used for each experiment. Synaptic puncta quantification. Methods for synaptic puncta quantification were adapted from Mosca and Luo 42 for use in mice. To quantify the volume and density of mRuby-labelled puncta from GPe-PV neuron termini in the SNr, 300 nl of AAVFLEx loxP -mGFP-2A-synaptophysin-mRuby was injected into the GPe of Pvalb-Cre mice, and sections were cut at a thickness of 60 μ m. Floating sections were stained using anti-mCherry and anti-GFP antibodies. Sections were imaged on a Zeiss 510 confocal microscope using a 63× objective, with image stacks containing 30 sections at 0.44 μ m intervals using 2× averaging and 2× optical zoom. Three images were taken of puncta in the SNr and subthalamic nucleus (STN) of each brain. Images were analysed using Imaris (Bitplane). The surface function was used to obtain the volume of mGFP + neurites and mRuby + puncta, while the spots function was used to estimate the number of mRuby + puncta. Data from the three slices from the SNr and STN were averaged for each brain. Measurements from the SNr were normalized to those from the STN. Quantification of Fos immunostaining. To quantify integrated neural activity, Cre-dependent AAVs expressing YFP, hM4Di, ChR2 or K ir 2.1 were injected into the GPe of Pvalb-Cre mice and relative activation of VTA-DA neurons was measured by the ratio of Fos + neurons in the ventral midbrain that co-stained with TH to all Fos + neurons in the ventral midbrain (Fig. 5g-i ). Animals were euthanized 90 min after the final stimulus (optical stimulation at 20 Hz for 30 min in ChR2-expressing animals, or cocaine or saline injection). When cocaine or saline was injected in animals expressing hM4Di, CNO was injected thirty minutes before the cocaine or saline injection. Animals were transcardially perfused, and Article reSeArcH brains sectioned on a vibratome in PBS. Sections were blocked with 10% normal donkey serum (NDS) and 2% BSA/0.5% triton-X100 in PBS (PBST), then stained with TH and Fos antibodies in 1% NDS in PBST at 4 °C for four nights. Sections were rinsed three times for 30 min each at room temperature, followed by secondary antibody stain in 1% NDS in PBST at 4 °C for two nights. Sections were then rinsed three times for 30 min each, and mounted on slides. The midbrain from three representative VTA-containing sections were then imaged on a Zeiss LSM 780 confocal microscope at 20× magnification, and the results averaged together for each brain. For activation of GPe neurons for Fos immunostaining, 300 nl of AAV-FLEx loxP -ChR2 was injected bilaterally into the GPe of Pvalb-Cre mice, and 200 μ m, 0.39NA optical fibres were implanted over the VTA. For stimulation, the optical fibre was connected to a 473 nm laser diode (OEM Laser systems) through an FC/PC adaptor. Laser output was controlled using a Master-8 pulse stimulation, which delivered 5 ms light pulses at 20 Hz. Light output through the optical fibres was adjusted to 20 mW using a digital power meter console. Images were taken with a constant exposure time. Cells with a visually identifiable nuclear label by eye were considered Fos + .
Immunohistochemistry.
The following primary antibodies were used: rat antimCherry, Life Sciences, 1:2,000; chicken anti-GFP, Aves Labs, 1:1,000; rabbit anti-TH, Millipore, 1:1,000; goat anti-Fos, Santa Cruz, 1:500. The following secondary antibodies were used from Jackson ImmunoResearch at a concentration of 1:250: donkey anti-chicken AlexaFluor488; donkey anti-goat AlexaFluor488; donkey anti-rat AlexaFluor555; donkey anti-goat AlexaFluor555; donkey antirabbit AlexaFluor647. Fibre photometry. To assess cocaine-induced changes in neuronal activity in vivo, fibre photometry was used 43 . We injected 750 nl of AAV-FLEx loxP -GCaMP6f into the GPe of Pvalb-Cre mice, and implanted a 400 μ m diameter, 0.48NA optical fibre (Doric Lenses) at the same location. To test the effect of GPe-PV neuron stimulation on VTA-DA neuron activity, 300 nl of AAV-FLEx FRT -bReachES was injected into the GPe, and 750 nl of AAV-FLEx loxP -GCaMP6f was injected into the VTA of DAT-Cre;Pvalb-Flp mice. A 400 μ m diameter, 0.48NA optical fibre was implanted over the VTA, and a 200 μ m, 0.39NA fibre (made in-house) was implanted over the GPe. Implants were secured to the skull with metal screws (Antrin Miniature Specialists), Metabond (Parkell), and Geristore dental epoxy (DenMat). Mice were allowed to recover for at least 4 weeks before experiments.
Fibre photometry recordings were made using previously described equipment 9 . In brief, 405 nm and 470 nm excitation light was used to excite GCaMP6f at its isosbestic and calcium-dependent wavelengths to obtain both a control and calcium signal in the same animal, respectively. To activate bReachES-expressing GPe-PV neurons, a 594 nm laser was controlled by a Master-8 pulse stimulation (A.M.P.I.) that delivered 5 ms pulses at 40 Hz. Light output through the optical fibres was adjusted to 10 mW using a digital power meter console (Thorlabs). Light was manually switched on at 10 min and off at 20 min.
All data analysis was performed in MATLAB. Signals were first motion corrected by subtracting the least squares best fit of the control trace to the calcium signal. Data points containing large motion artefacts were then manually removed. To assess neural activity, the median absolute deviation (MAD) was calculated across the entire photometry trace during a given session. We conservatively defined a threshold of 6 × MAD to assess bouts of high neural activity. During each session, we calculated the percentage of time that the photometry trace was greater than or equal to 6 × MAD of the entire trace. For Fig. 2i-k Labelled neurons were visualized with a 40× water-immersion objective on an upright fluorescent microscope (BX51WI; Olympus) equipped with infrareddifferential interference contrast video microscopy and epifluorescence (Olympus). ChR2 was stimulated by flashing 473-nm light (2 ms pulses, 0.1 Hz, 10 mW) through the light path of the microscope using an ultrahigh-powered light-emitting diode (LED) powered by an LED driver (Thorlabs) under computer control. The light intensity of the LED was not changed during the experiments. A dual lamp house adaptor (Olympus) was used to switch between the fluorescence lamp and LED light source.
For monosynaptic connectivity analysis, d-APV (50 μ M) and NBQX (10 μ M) were added to block NMDA receptors and AMPA receptors, respectively, and tetrodotoxin (TTX, 1 μ M), a voltage-gated sodium channel antagonist, and 4-aminopyridine (4-AP, 1mM), a potassium channel antagonist, were added to isolate monosynaptic connections 44 . The IPSC amplitude plotted in Fig. 5c included only cells with detectable optically evoked IPSCs.
For analysis of quantal size and frequency from GPe inputs to SNr neurons, we replaced calcium in the ACSF with 4 mM SrCl 2 to induce asynchronous vesicle release. The amplitude and frequency of events occurring between 50 ms and 250 ms after the blue light pulse were recorded. The amplitude of each event was measured from a local baseline established 5-10 ms before the light pulse. All electrophysiology data were collected using Axograph software. To assay for drug-induced CPP, animals were first tested in a single drug pairing, two-chamber CPP test. Each chamber was given either a clear, textured or black, smooth floor. On the first day, animals were initially placed into the right chamber, and allowed to freely explore both chambers for thirty minutes (pre-test). On the second day, animals were saline-conditioned to the left side, and on the following day, cocaine (or morphine)-conditioned to the right side. Drug conditioning on the black, smooth or clear, textured floor was counterbalanced across the mice. On the fourth day, animals were again initially placed into the right chamber, and allowed to explore freely (post-test). For animals injected with CNO, 10 mg/kg CNO was injected thirty minutes before the beginning of the cocaine and saline pairings.
The following week, to test LMS, animals were habituated to open field boxes equipped with motion tracking for two days (receiving saline injections before each session). Animals were then injected with cocaine (or morphine) immediately before entry into the open-field boxes, for five consecutive days, for 30 min each. For animals injected with CNO, CNO was delivered 30 min before the beginning of each session. In Extended Data Fig. 5 , both YFP and hM4Di-expressing animals were given CNO 30 min before morphine injection.
To inhibit GPe-PV neurons that project to the midbrain, 500 nl of CAV2-FLEx loxP -Flp was injected into the SNr, and 300 nl of AAV-FLEx FRT -K ir 2.1 was injected into the GPe of Pvalb-Cre mice. All injections were bilateral. Animals were tested 2 weeks later.
To inhibit GPe-PV terminals in the midbrain, animals were injected with 300 nl of AAV-FLEx loxP -YFP or AAV-FLEx loxP -hM4Di in the GPe, and a bilateral cannula guide (C235G, 26GA, C/C distance 1.8 mm, 5 mm pedestal, cut 3.5 mm below pedestal, custom specified for mouse bilateral ventral midbrain coordinates, Plastics One) was implanted over the ventral midbrain (coordinates AP − 3.5, ML 0.9, DV − 3.13). Two skull screws were implanted for headcap stability, and headcaps were sealed with Metabond and Geristore. CNO microspheres were synthesized to enable slow release of CNO after a single infusion. Degradex PLGA CNO microspheres were custom ordered from Phosphorex. Beads of target mean diameter 1 μ m were dissolved in 0.5% trehalose at a concentration of 5 mg microsphere per ml. The estimated CNO loading efficiency was 5%, the estimated burst release was 50%, and the estimated release time was 7 days. The target concentration of CNO release at a steady state was 100 pg/h 23, 45 . On day 1 of the behavioural protocols, animals were given an IP saline injection. On day 2, one hour before locomotor testing, all cannula guides were pierced with a dummy infuser (C235I, 33GA, project 1.5 MM past guide), and mice were given an IP saline injection one hour later. On day 3, CNO microspheres were infused one hour before locomotor testing, 250 nl per side at 250 nl/min, and mice were given an IP saline injection one hour later and tested for effects on basal locomotion. On days 3-6, animals were run through the CPP protocol, and on days 6-10 (starting on the same afternoon) they were run through the LMS protocol. We then waited a week for CNO washout, and repeated the standard CPP and LMS procedures without subsequent infusions in hM4Di-expressing animals. For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
MATLAB software was used to analyze fiber photometry data All electrophysiology data were collected using Axograph software.
GraphPad Prism was used to analyze all other data.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
There are no restrictions on materials.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
The following primary antibodies were used: Rat anti-mCherry, Life Sciences, 1:2000; chicken anti-GFP, Aves Labs, 1:1000; rabbit anti-TH, Millipore, 1:1000; Goat anti-Fos, Santa Cruz, 1:500. The following secondary antibodies were used from Jackson ImmunoResearch at a concentration of 1:250: donkey anti-chicken AlexaFluor488; donkey anti-goat AlexaFluor488; donkey anti-rat AlexaFluor555; donkey anti-goat AlexaFluor555; donkey anti-rabbit AlexaFluor647.
Antibodies were validated 1. In the case of an extensively published antibody, by testing the specificity of staining to the appropriate regions (e.g. tyrosine hydroxylase, TH), or 2. by comparing between animals (e.g. cFos) and noting labeling that is above background but not consistent with non-specific staining.
